Cardiac safety implications of hNav1.5 blockade and a framework for pre-clinical evaluation
FRONTIERS IN PHARMACOLOGY (2012)
期刊
FRONTIERS IN PHARMACOLOGY
卷 3, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
关键词
作者
我是这篇论文的作者
推荐
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
Balazs Horvath, Norbert Szentandrassy, Janos Almassy, Csaba Dienes, Zsigmond Mate Kovacs, Peter P. Nanasi, Tamas Banyasz
PHARMACEUTICALS (2022)
Eugenol interacts with cardiac sodium channel and reduces heart excitability and arrhythmias
Jorge Lucas Teixeira-Fonseca, Artur Santos-Miranda, Joab Barbosa da Silva, Leisiane Pereira Marques, Julliane Vasconcelos Joviano-Santos, Paula Idma Chaves Nunes, Danilo Roman-Campos, Antonio Nei Santana Gondim
LIFE SCIENCES (2021)
ECG-NET: A deep LSTM autoencoder for detecting anomalous ECG
Moumita Roy, Sukanta Majumder, Anindya Halder, Utpal Biswas
ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE (2023)
Functional cross-talk between phosphorylation and disease-causing mutations in the cardiac sodium channel Nav1.5
Iacopo Galleano, Hendrik Harms, Koushik Choudhury, Keith Khoo, Lucie Delemotte, Stephan Alexander Pless
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models
Gary Tse, Ka Hou Christien Li, Chloe Kwong Yee Cheung, Konstantinos P. Letsas, Aishwarya Bhardwaj, Abhishek C. Sawant, Tong Liu, Gan-Xin Yan, Henggui Zhang, Kamalan Jeevaratnam, Nazish Sayed, Shuk Han Cheng, Wing Tak Wong
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Subcellular diversity of Nav1.5 in cardiomyocytes: distinct functions, mechanisms and targets
Gerard A. Marchal, Carol Ann Remme
JOURNAL OF PHYSIOLOGY-LONDON (2023)
Prokaryotic voltage-gated sodium channels are more effective than endogenous Nav1.5 channels in rescuing cardiac action potential conduction: an in silico study
Daniel Needs, Tianyu Wu, Hung X. Nguyen, Craig S. Henriquez, Nenad Bursac
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2023)
ECGTransForm: Empowering adaptive ECG arrhythmia classification framework with bidirectional transformer
Hany El-Ghaish, Emadeldeen Eldele
BIOMEDICAL SIGNAL PROCESSING AND CONTROL (2024)
Cardiac sodium channel complexes and arrhythmia: structural and functional roles of the β1 and β3 subunits
Samantha C. Salvage, Kamalan Jeevaratnam, Christopher L. -H. Huang, Antony P. Jackson
JOURNAL OF PHYSIOLOGY-LONDON (2023)
ECG Language processing (ELP): A new technique to analyze ECG
Sajad Mousavi, Fatemeh Afghah, Fatemeh Khadem, U. Rajendra Acharya
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2021)
Identification of rare heterozygous linkage R965C-R1309H mutations in the pore-forming region of SCN5A gene associated with complex arrhythmia
Yubi Lin, Jiading Qin, Yuhui Shen, Jiana Huang, Zuoquan Zhang, ZhiLing Zhu, Huifang Lu, Yin Huang, Yuelan Yin, Ani Wang, Lizi Jin, Zhenyu Hu, Xiufang Lin, Bin Jiang
MOLECULAR GENETICS & GENOMIC MEDICINE (2021)
Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance
Stephanie Cerceo Page, Srinidhi Rao Sripathy, Federica Farinelli, Zengyou Ye, Yanhong Wang, Daniel J. Hiler, Elizabeth A. Pattie, Claudia Nguyen, Madhavi Tippani, Rebecca L. Moses, Huei-Ying Chen, Matthew Nguyen Tran, Nicholas J. Eagles, Joshua M. Stolz, Joseph L. I. I. I. I. Catallini, Olivia R. Soudry, Dwight Dickinson, Karen F. Berman, Jose A. Apud, Daniel R. Weinberger, Keri Martinowich, Andrew E. Jaffe, Richard E. Straub, Brady J. Maher
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Late sodium current: incomplete inactivation triggers seizures, myotonias, arrhythmias, and pain syndromes
Mohamed A. Fouda, Mohammad-Reza Ghovanloo, Peter C. Ruben
JOURNAL OF PHYSIOLOGY-LONDON (2022)
MVKT-ECG: Efficient single-lead ECG classification for multi-label arrhythmia by multi-view knowledge transferring
Yuzhen Qin, Li Sun, Hui Chen, Wenming Yang, Wei-Qiang Zhang, Jintao Fei, Guijin Wang
COMPUTERS IN BIOLOGY AND MEDICINE (2023)
Absence of Arrhythmogenicity with Biphasic Pulsed Electric Fields Delivered to Porcine Airways
Glenn R. R. Meininger, Robert E. E. Neal II, David W. W. Hunter, William S. S. Krimsky
ANNALS OF BIOMEDICAL ENGINEERING (2023)
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL
Nienke M. A. Idzerda, Lindsay E. Clegg, Adrian F. Hernandez, George Bakris, Robert C. Penland, David W. Boulton, M. Angelyn Bethel, Rury R. Holman, Hiddo J. L. Heerspink
DIABETES OBESITY & METABOLISM (2020)
Renal Effects of Dapagliflozin in People with and without Diabetes with Moderate or Severe Renal Dysfunction: Prospective Modeling of an Ongoing Clinical Trial
K. Melissa Hallow, David W. Boulton, Robert C. Penland, Gabriel Helmlinger, Emily H. Nieves, Daniel H. van Raalte, Hiddo L. Heerspink, Peter J. Greasley
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: Apost hocanalysis of theEXSCELtrial
Annemarie B. van der Aart-van der Beek, Lindsay E. Clegg, Robert C. Penland, David W. Boulton, C. David Sjostrom, Robert J. Mentz, Rury R. Holman, Hiddo J. L. Heerspink
DIABETES OBESITY & METABOLISM (2020)
Predicted Cardiac Hemodynamic Consequences of the Renal Actions of SGLT2i in the DAPA-HF Study Population: A Mathematical Modeling Analysis
Hongtao Yu, Weifeng Tang, Peter J. Greasley, Robert C. Penland, David W. Boulton, K. Melissa Hallow
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials
Lindsay E. Clegg, Yankang Jing, Robert C. Penland, David W. Boulton, Adrian F. Hernandez, Rury R. Holman, Jiten Vora
DIABETES OBESITY & METABOLISM (2021)
A model-based approach to investigating the relationship between glucose-insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes
Millie Shah, Leonid Stolbov, Tatiana Yakovleva, Weifeng Tang, Victor Sokolov, Robert C. Penland, David Boulton, Joanna Parkinson
DIABETES OBESITY & METABOLISM (2021)
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Aditi R. Saxena, Donal N. Gorman, Ryan M. Esquejo, Arthur Bergman, Kristin Chidsey, Clare Buckeridge, David A. Griffith, Albert M. Kim
NATURE MEDICINE (2021)
Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis
Hongtao Yu, Sanchita Basu, Weifeng Tang, Robert C. Penland, Peter J. Greasley, Jan Oscarsson, David W. Boulton, K. Melissa Hallow
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus
Johanna Melin, Weifeng Tang, Dinko Rekic, Bengt Hamren, Robert C. Penland, David W. Boulton, Joanna Parkinson
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes
Aditi R. Saxena, Stephanie-An Lyle, Kaivan Khavandi, Ruolun Qiu, Mark Whitlock, William P. Esler, Albert M. Kim
DIABETES OBESITY & METABOLISM (2023)
Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus
Robert C. Penland, Johanna Melin, David W. Boulton, Weifeng Tang
JOURNAL OF CLINICAL PHARMACOLOGY (2023)
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
Victor Sokolov, Tatiana Yakovleva, Leonid Stolbov, Robert C. Penland, David Boulton, Joanna Parkinson, Weifeng Tang
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)
Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus
Johanna Melin, Joanna Parkinson, Bengt Hamren, Robert C. Penland, David W. Boulton, Weifeng Tang
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study
Lindsay E. Clegg, Lulu Chu, Mats Nagard, David W. Boulton, Robert C. Penland
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)
Differentiating the Sodium-Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling
Victor Sokolov, Tatiana Yakovleva, Chu Lulu, Tang Weifeng, Peter J. Greasley, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W. Boulton, Robert C. Penland
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)